Among them, two patients with iCCAs harboring the G12D mutation in KRAS developed the fastest onset of tumor metastasis following surgery, with a progression-free survival period of only 4 months for patient S428 and 7 months for patient S430. This evidence concerns the gene KRAS and neoplasm.